Virginia Retirement Systems Et Al Rhythm Pharmaceuticals, Inc. Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 6,700 shares of RYTM stock, worth $717,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,700Holding current value
$717,905% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
252Shares Held
64.3MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$722 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$601 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$596 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$523 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$385 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.97B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...